Melqart Asset Management (UK) Ltd
London, X0 · CIK 1712901 · 13F filing filed 2020-02-14
SEC-registered investment adviser since 2022 · other (specify)
- Assets managed$2.9bn
- Staff23 · 13 in investment roles
- Main clients (by assets)Private funds 88%, Companies 12%
- Private funds2 (2 hedge) · $2.4bn gross assets
- Websitemelqart.com
- Form ADV · 2026-02-25SEC adviser record
- Legal entityMELQART ASSET MANAGEMENT (UK) LTD (GB)
- Kindhedge funds, futures, FCA fund manager
- Others nearbyLondon
As an employer
- Offices in1 country
- Private fundshedge 2
In the UK
- FCA-authorised companies1
- Manages investmentsyes
- Runs fundsyes
- Retail clientsno, professional only
| Company | Staff |
|---|---|
| MELQART ASSET MANAGEMENT (UK) LTD Private Limited CompanyFCA: Authorised · manages investments, manages AIFs, advises, deals |
Sources: Companies House (accounts filed electronically; the largest groups often file on paper, so their staff numbers can be missing), the UK gender pay gap service (employers with 250+ staff) and the FCA's Financial Services Register. Contains public sector information licensed under the Open Government Licence v3.0.
$1.1bn
reported value
36positions
63.1%in top 10
—no comparable previous quarter
Options: 2 call positions ($34.7m notional), 2 put positions ($14.7m notional) – listed below, not included above.
Holdings, Q4 2019
The small lines show how much was held over the last 4 quarters (adjusted for stock splits).
| Security | Value | Change |
|---|---|---|
| ALLERGAN PLC ACT | $134.6m11.76% | — |
| NXP SEMICONDUCTORS N V NXPI | $97.3m8.51% | — |
| CYPRESS SEMICONDUCTOR CORP CY | $79.6m6.96% | — |
| ZAYO GROUP HLDGS INC ZAYO | $76.3m6.66% | — |
| IAC INTERACTIVECORP IACI | $66.9m5.84% | — |
| MELLANOX TECHNOLOGIES LTD MLNX | $64.1m5.60% | — |
| VERTEX PHARMACEUTICALS INC VRTX | $63.0m5.51% | — |
| WABCO HLDGS INC COM | $51.9m4.54% | — |
| TIFFANY & CO NEW TIF | $47.0m4.11% | — |
| WRIGHT MED GROUP N V WMGI | $41.7m3.65% | — |
| AVAYA HLDGS CORP AVYA | $41.2m3.60% | — |
| INTERXION HOLDING N.V INXN | $40.2m3.52% | — |
| LOGMEIN INC LOGM | $34.9m3.05% | — |
| HILTON GRAND VACATIONS INC HGV | $32.8m2.87% | — |
| TAKEDA PHARMACEUTICAL CO LTD TAK | $30.7m2.68% | — |
| TECH DATA CORP COM | $26.6m2.32% | — |
| INSTRUCTURE INC INST | $20.8m1.82% | — |
| QIWI PLC QIWI | $20.6m1.80% | — |
| MEDICINES CO MDCO | $20.3m1.77% | — |
| CISION LTD CISN | $19.7m1.72% | — |
| ASCENDIS PHARMA A/S SPONSORED ADR | $16.1m1.40% | — |
| RINGCENTRAL INC RNG | $12.6m1.10% | — |
| QIAGEN NV SHS NEW | $12.5m1.09% | — |
| ATLASSIAN CORP PLC CL A | $12.4m1.08% | — |
| TWILIO INC TWLO | $11.8m1.03% | — |
| CLEVELAND-CLIFFS INC NEW CLF | $11.5m1.01% | — |
| FARFETCH LTD FTCHQ | $11.3m0.98% | — |
| FITBIT INC FIT | $9.8m0.85% | — |
| QUINTANA ENERGY SVCS INC QES | $9.2m0.81% | — |
| ARQULE INC ARQL | $7.4m0.64% | — |
| BRISTOL-MYERS SQUIBB CO BMY-R | $5.4m0.47% | — |
| FIVE9 INC FIVN | $4.5m0.40% | — |
| INTELSAT S A I2EUR | $3.9m0.34% | — |
| AVAYA HLDGS CORP AVYA 2.25 06.15.23 · principal | $2.3m0.20% | — |
| CYRUSONE INC COM | $2.3m0.20% | — |
| AUDENTES THERAPEUTICS INC BOLD | $1.1m0.09% | — |
Options (notional value)
| Underlying | Notional | Change |
|---|---|---|
| MEDICINES CO MDCO · Call | $31.8m374.2k shares | — |
| AUDENTES THERAPEUTICS INC BOLD · Put | $13.8m230.0k shares | — |
| INTELSAT S A I2EUR · Call | $2.9m410.5k shares | — |
| ARQULE INC ARQL · Put | $890.0k44.6k shares | — |